One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla.
An enkephalin analog that selectively binds to the MU OPIOID RECEPTOR. It is used as a model for drug permeability experiments.
One of the endogenous pentapeptides with morphine-like activity. It differs from MET-ENKEPHALIN in the LEUCINE at position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN.
One of the endogenous pentapeptides with morphine-like activity. It differs from LEU-ENKEPHALIN by the amino acid METHIONINE in position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN.
A disulfide opioid pentapeptide that selectively binds to the DELTA OPIOID RECEPTOR. It possesses antinociceptive activity.
A delta-selective opioid (ANALGESICS, OPIOID). It can cause transient depression of mean arterial blood pressure and heart rate.
One of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group.
Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known.
A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine.
A class of cell surface receptors for tachykinins that prefers neurokinin B (neurokinin beta, neuromedin K) over other tachykinins. Neurokinin-3 (NK-3) receptors have been cloned and are members of the G-protein coupled receptor superfamily. They have been found in the central nervous system and in peripheral tissues.
A class of opioid receptors recognized by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins.
A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ A with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the URINARY BLADDER and UTERUS.
A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.
A kappa opioid receptor agonist. The compound has analgesic action and shows positive inotropic effects on the electrically stimulated left atrium. It also affects various types of behavior in mammals such as locomotion, rearing, and grooming.
A family of biologically active peptides sharing a common conserved C-terminal sequence, -Phe-X-Gly-Leu-Met-NH2, where X is either an aromatic or a branched aliphatic amino acid. Members of this family have been found in mammals, amphibians, and mollusks. Tachykinins have diverse pharmacological actions in the central nervous system and the cardiovascular, genitourinary, respiratory, and gastrointestinal systems, as well as in glandular tissues. This diversity of activity is due to the existence of three or more subtypes of tachykinin receptors.
Cell surface proteins that bind TACHYKININS with high affinity and trigger intracellular changes influencing the behavior of cells. Three classes of tachykinin receptors have been characterized, the NK-1; NK-2; and NK-3; which prefer, respectively, SUBSTANCE P; NEUROKININ A; and NEUROKININ B.
An analgesic with mixed narcotic agonist-antagonist properties.
A stable synthetic analog of methionine enkephalin (ENKEPHALIN, METHIONINE). Actions are similar to those of methionine enkephalin. Its effects can be reversed by narcotic antagonists such as naloxone.
A class of opioid receptors recognized by its pharmacological profile. Kappa opioid receptors bind dynorphins with a higher affinity than endorphins which are themselves preferred to enkephalins.
An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses.
A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ B with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the BRONCHI.
Agents inhibiting the effect of narcotics on the central nervous system.
The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.
A class of cell surface receptors for tachykinins that prefers neurokinin A; (NKA, substance K, neurokinin alpha, neuromedin L), neuropeptide K; (NPK); or neuropeptide gamma over other tachykinins. Neurokinin-2 (NK-2) receptors have been cloned and are similar to other G-protein coupled receptors.
A class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors (RECEPTORS, OPIOID, KAPPA) and have been shown to play a role as central nervous system transmitters.
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.
A transfer RNA which is specific for carrying glycine to sites on the ribosomes in preparation for protein synthesis.
A ZINC-containing exopeptidase primarily found in SECRETORY VESICLES of endocrine and neuroendocrine cells. It catalyzes the cleavage of C-terminal ARGININE or LYSINE residues from polypeptides and is active in processing precursors of PEPTIDE HORMONES and other bioactive peptides.
Morphine derivatives of the methanobenzazocine family that act as potent analgesics.
Compounds based on benzeneacetamide, that are similar in structure to ACETANILIDES.
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
A 31-amino acid peptide that is the C-terminal fragment of BETA-LIPOTROPIN. It acts on OPIOID RECEPTORS and is an analgesic. Its first four amino acids at the N-terminal are identical to the tetrapeptide sequence of METHIONINE ENKEPHALIN and LEUCINE ENKEPHALIN.
A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.
The endogenous peptides with opiate-like activity. The three major classes currently recognized are the ENKEPHALINS, the DYNORPHINS, and the ENDORPHINS. Each of these families derives from different precursors, proenkephalin, prodynorphin, and PRO-OPIOMELANOCORTIN, respectively. There are also at least three classes of OPIOID RECEPTORS, but the peptide families do not map to the receptors in a simple way.
A narcotic antagonist similar in action to NALOXONE. It is used to remobilize animals after ETORPHINE neuroleptanalgesia and is considered a specific antagonist to etorphine.
Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS.
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS.
A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.
Peptides composed of between two and twelve amino acids.
A narcotic analgesic morphinan used as a sedative in veterinary practice.
A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
A class of cell surface receptors for TACHYKININS with a preference for SUBSTANCE P. Neurokinin-1 (NK-1) receptors have been cloned and are members of the G protein coupled receptor superfamily. They are found on many cell types including central and peripheral neurons, smooth muscle cells, acinar cells, endothelial cells, fibroblasts, and immune cells.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Protein precursors, also known as proproteins or prohormones, are inactive forms of proteins that undergo post-translational modification, such as cleavage, to produce the active functional protein or peptide hormone.
Compounds capable of relieving pain without the loss of CONSCIOUSNESS.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
The relationship between the dose of an administered drug and the response of the organism to the drug.
Compounds based on a partially saturated iminoethanophenanthrene, which can be described as ethylimino-bridged benzo-decahydronaphthalenes. They include some of the OPIOIDS found in PAPAVER that are used as ANALGESICS.
Sulfhydryl acylated derivative of GLYCINE.
Enzyme that is a major constituent of kidney brush-border membranes and is also present to a lesser degree in the brain and other tissues. It preferentially catalyzes cleavage at the amino group of hydrophobic residues of the B-chain of insulin as well as opioid peptides and other biologically active peptides. The enzyme is inhibited primarily by EDTA, phosphoramidon, and thiorphan and is reactivated by zinc. Neprilysin is identical to common acute lymphoblastic leukemia antigen (CALLA Antigen), an important marker in the diagnosis of human acute lymphocytic leukemia. There is no relationship with CALLA PLANT.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
The inner portion of the adrenal gland. Derived from ECTODERM, adrenal medulla consists mainly of CHROMAFFIN CELLS that produces and stores a number of NEUROTRANSMITTERS, mainly adrenaline (EPINEPHRINE) and NOREPINEPHRINE. The activity of the adrenal medulla is regulated by the SYMPATHETIC NERVOUS SYSTEM.
A family of hexahydropyridines.
The most anterior portion of the uveal layer, separating the anterior chamber from the posterior. It consists of two layers - the stroma and the pigmented epithelium. Color of the iris depends on the amount of melanin in the stroma on reflection from the pigmented epithelium.
A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
The rate dynamics in chemical or physical systems.
Pyrrolidines are saturated, heterocyclic organic compounds containing a five-membered ring with four carbon atoms and one nitrogen atom (NRCH2CH2), commonly found as structural components in various alkaloids and used in the synthesis of pharmaceuticals and other organic materials.
Organelles in CHROMAFFIN CELLS located in the adrenal glands and various other organs. These granules are the site of the synthesis, storage, metabolism, and secretion of EPINEPHRINE and NOREPINEPHRINE.
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal.
The representation of the phylogenetically oldest part of the corpus striatum called the paleostriatum. It forms the smaller, more medial part of the lentiform nucleus.
Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion.
Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL.
A semisynthetic analgesic used in the study of narcotic receptors.
The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
The excretory duct of the testes that carries SPERMATOZOA. It rises from the SCROTUM and joins the SEMINAL VESICLES to form the ejaculatory duct.
Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.
Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding.
Enzymes that act at a free C-terminus of a polypeptide to liberate a single amino acid residue.
The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements.
Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
BENZOIC ACID amides.
The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).
Injections into the cerebral ventricles.
Introduction of therapeutic agents into the spinal region using a needle and syringe.
Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE.
Compounds containing the PhCH= radical.
One of two ganglionated neural networks which together form the ENTERIC NERVOUS SYSTEM. The myenteric (Auerbach's) plexus is located between the longitudinal and circular muscle layers of the gut. Its neurons project to the circular muscle, to other myenteric ganglia, to submucosal ganglia, or directly to the epithelium, and play an important role in regulating and patterning gut motility. (From FASEB J 1989;3:127-38)
Bluish-colored region in the superior angle of the FOURTH VENTRICLE floor, corresponding to melanin-like pigmented nerve cells which lie lateral to the PERIAQUEDUCTAL GRAY.
The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.
The parts of a macromolecule that directly participate in its specific combination with another molecule.
Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES).
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.
Analogs or derivatives of morphine.
A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders).
A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER.
A neuropeptide of 29-30 amino acids depending on the species. Galanin is widely distributed throughout the BRAIN; SPINAL CORD; and INTESTINES. There are various subtypes of GALANIN RECEPTORS implicating roles of galanin in regulating FOOD INTAKE; pain perception; memory; and other neuroendocrine functions.

Enkephalins are naturally occurring opioid peptides that bind to opiate receptors in the brain and other organs, producing pain-relieving and other effects. They are derived from the precursor protein proenkephalin and consist of two main types: Leu-enkephalin and Met-enkephalin. Enkephalins play a role in pain modulation, stress response, mood regulation, and addictive behaviors. They are also involved in the body's reward system and have been implicated in various physiological processes such as respiration, gastrointestinal motility, and hormone release.

Enkephalins are naturally occurring opioid peptides in the body that bind to opiate receptors and help reduce pain and produce a sense of well-being. There are two major types of enkephalins: Met-enkephalin and Leu-enkephalin, which differ by only one amino acid at position 5 (Leucine or Methionine).

Leu-enkephalin, also known as YGGFL, is a type of enkephalin that contains the amino acids Tyrosine (Y), Glycine (G), Glycine (G), Phenylalanine (F), and Leucine (L) in its sequence. It is involved in pain regulation, mood, and other physiological processes.

Leu-enkephalin is synthesized from a larger precursor protein called proenkephalin and is stored in the secretory vesicles of neurons. When released into the synaptic cleft, Leu-enkephalin can bind to opioid receptors on neighboring cells, leading to various physiological responses.

Leu-enkephalin has a shorter half-life than Met-enkephalin due to its susceptibility to enzymatic degradation by peptidases. However, it still plays an essential role in modulating pain and other functions in the body.

Enkephalins are naturally occurring opioid peptides in the body that bind to opiate receptors and help reduce pain and produce a sense of well-being. There are two major types of enkephalins: Leu-enkephalin and Met-enkephalin, which differ by only one amino acid at the N-terminus.

Methionine-enkephalin (Met-enkephalin) is a type of enkephalin that contains methionine as its N-terminal amino acid. Its chemical formula is Tyr-Gly-Gly-Phe-Met, and it is derived from the precursor protein proenkephalin. Met-enkephalin has a shorter half-life than Leu-enkephalin due to its susceptibility to enzymatic degradation by aminopeptidases.

Met-enkephalin plays an essential role in pain modulation, reward processing, and addiction. It is also involved in various physiological functions, including respiration, cardiovascular regulation, and gastrointestinal motility. Dysregulation of enkephalins has been implicated in several pathological conditions, such as chronic pain, drug addiction, and neurodegenerative disorders.

Enkephalins are naturally occurring opioid peptides in the body that bind to opiate receptors and help reduce pain and produce a sense of well-being. There are several different types of enkephalins, including Leu-enkephalin and Met-enkephalin, which differ based on their amino acid sequence.

Leucine-enkephalin (Leu-Enk) is a specific type of enkephalin that contains the amino acids tyrosine, glycine, glutamic acid, leucine, and methionine in its sequence. The Leucine-2-Alanine variant of Leu-Enk refers to a synthetic form of this peptide where the leucine at position 2 is replaced with alanine. This modification can affect the stability, activity, and pharmacological properties of the enkephalin molecule.

It's important to note that while Leu-Enk and its analogs have potential therapeutic applications in pain management, they are also subject to abuse and addiction due to their opioid properties. Therefore, their use is tightly regulated and requires careful medical supervision.

Endorphins are a type of neurotransmitter, which are chemicals that transmit signals in the nervous system and brain. The term "endorphin" comes from "endogenous morphine," reflecting the fact that these substances are produced naturally within the body and have effects similar to opiate drugs like morphine.

Endorphins are released in response to stress or pain, but they also occur naturally during exercise, excitement, laughter, love, and orgasm. They work by interacting with the opiate receptors in the brain to reduce the perception of pain and promote feelings of pleasure and well-being. Endorphins also play a role in regulating various physiological processes, including appetite, mood, and sleep.

In summary, endorphins are natural painkillers and mood elevators produced by the body in response to stress, pain, or enjoyable activities.

Opioid receptors are a type of G protein-coupled receptor (GPCR) found in the cell membranes of certain neurons in the central and peripheral nervous system. They bind to opioids, which are chemicals that can block pain signals and produce a sense of well-being. There are four main types of opioid receptors: mu, delta, kappa, and nociceptin. These receptors play a role in the regulation of pain, reward, addiction, and other physiological functions. Activation of opioid receptors can lead to both therapeutic effects (such as pain relief) and adverse effects (such as respiratory depression and constipation).

Opioid mu receptors, also known as mu-opioid receptors (MORs), are a type of G protein-coupled receptor that binds to opioids, a class of chemicals that include both natural and synthetic painkillers. These receptors are found in the brain, spinal cord, and gastrointestinal tract, and play a key role in mediating the effects of opioid drugs such as morphine, heroin, and oxycodone.

MORs are involved in pain modulation, reward processing, respiratory depression, and physical dependence. Activation of MORs can lead to feelings of euphoria, decreased perception of pain, and slowed breathing. Prolonged activation of these receptors can also result in tolerance, where higher doses of the drug are required to achieve the same effect, and dependence, where withdrawal symptoms occur when the drug is discontinued.

MORs have three main subtypes: MOR-1, MOR-2, and MOR-3, with MOR-1 being the most widely studied and clinically relevant. Selective agonists for MOR-1, such as fentanyl and sufentanil, are commonly used in anesthesia and pain management. However, the abuse potential and risk of overdose associated with these drugs make them a significant public health concern.

Neurokinin-3 (NK-3) receptors are a type of G protein-coupled receptor that binds the neuropeptide neurokinin B, which is a member of the tachykinin family. These receptors are widely distributed in the central and peripheral nervous systems and play important roles in various physiological functions, including the regulation of nociception (pain perception), inflammation, and reproduction.

NK-3 receptors have been identified as key mediators of female reproductive function, particularly in the hypothalamus where they are involved in the control of gonadotropin-releasing hormone (GnRH) secretion. Dysregulation of NK-3 receptor signaling has been implicated in several reproductive disorders, including polycystic ovary syndrome and endometriosis.

In addition to their role in reproduction, NK-3 receptors have also been implicated in various neurological and psychiatric conditions, such as anxiety, depression, and drug addiction. As a result, NK-3 receptor antagonists have emerged as potential therapeutic targets for the treatment of these disorders.

Opioid delta receptors, also known as delta opioid receptors (DORs), are a type of G protein-coupled receptor found in the nervous system and other tissues throughout the body. They belong to the opioid receptor family, which includes mu, delta, and kappa receptors. These receptors play an essential role in pain modulation, reward processing, and addictive behaviors.

Delta opioid receptors are activated by endogenous opioid peptides such as enkephalins and exogenous opioids like synthetic drugs. Once activated, they trigger a series of intracellular signaling events that can lead to inhibition of neuronal excitability, reduced neurotransmitter release, and ultimately, pain relief.

Delta opioid receptors have also been implicated in various physiological processes, including immune function, respiratory regulation, and gastrointestinal motility. However, their clinical use as therapeutic targets has been limited due to the development of tolerance and potential adverse effects such as sedation and respiratory depression.

In summary, delta opioid receptors are a type of opioid receptor that plays an essential role in pain modulation and other physiological processes. They are activated by endogenous and exogenous opioids and trigger intracellular signaling events leading to various effects, including pain relief. However, their clinical use as therapeutic targets is limited due to potential adverse effects.

Neurokinin B is a neuropeptide belonging to the tachykinin family, which also includes substance P and neurokinin A. It is encoded by the TAC3 gene in humans and is widely distributed throughout the central and peripheral nervous systems. Neurokinin B exerts its effects by binding to the neurokinin 3 receptor (NK3R) and plays a role in various physiological processes, including the regulation of feeding behavior, reproduction, and nociception (pain perception). It has also been implicated in several pathological conditions, such as inflammatory diseases, chronic pain, and certain types of cancer.

Naloxone is a medication used to reverse the effects of opioids, both illicit and prescription. It works by blocking the action of opioids on the brain and restoring breathing in cases where opioids have caused depressed respirations. Common brand names for naloxone include Narcan and Evzio.

Naloxone is an opioid antagonist, meaning that it binds to opioid receptors in the body without activating them, effectively blocking the effects of opioids already present at these sites. It has no effect in people who have not taken opioids and does not reverse the effects of other sedatives or substances.

Naloxone can be administered via intranasal, intramuscular, intravenous, or subcutaneous routes. The onset of action varies depending on the route of administration but generally ranges from 1 to 5 minutes when given intravenously and up to 10-15 minutes with other methods.

The duration of naloxone's effects is usually shorter than that of most opioids, so multiple doses or a continuous infusion may be necessary in severe cases to maintain reversal of opioid toxicity. Naloxone has been used successfully in emergency situations to treat opioid overdoses and has saved many lives.

It is important to note that naloxone does not reverse the effects of other substances or address the underlying causes of addiction, so it should be used as part of a comprehensive treatment plan for individuals struggling with opioid use disorders.

Ethylketocyclazocine is a synthetic opioid drug that acts as a potent mixed agonist-antagonist at mu, kappa, and delta opioid receptors. It produces analgesic, sedative, and respiratory depressant effects, but its clinical use is limited due to its strong dysphoric and hallucinogenic properties. Ethylketocyclazocine is primarily used in research to study the pharmacology of opioid receptors and their roles in pain modulation, addiction, and other physiological processes.

Tachykinins are a group of neuropeptides that share a common carboxy-terminal sequence and bind to G protein-coupled receptors, called tachykinin receptors. They are widely distributed in the nervous system and play important roles as neurotransmitters or neuromodulators in various physiological functions, such as pain transmission, smooth muscle contraction, and inflammation. The most well-known tachykinins include substance P, neurokinin A, and neuropeptide K. They are involved in many pathological conditions, including chronic pain, neuroinflammation, and neurodegenerative diseases.

Tachykinin receptors are a type of G protein-coupled receptor (GPCR) that bind and respond to tachykinins, which are neuropeptides involved in various physiological functions such as neurotransmission, smooth muscle contraction, vasodilation, and pain perception. There are three main subtypes of tachykinin receptors: NK1, NK2, and NK3.

NK1 receptors primarily bind substance P, a neuropeptide that plays a role in neurotransmission, inflammation, and pain signaling. NK2 receptors mainly bind neurokinin A (NKA) and are involved in smooth muscle contraction, particularly in the respiratory and gastrointestinal tracts. NK3 receptors primarily bind neurokinin B (NKB) and are found in the central nervous system, where they play a role in regulating body temperature, feeding behavior, and sexual function.

Tachykinin receptors have been implicated in various pathological conditions such as chronic pain, inflammation, asthma, and neurodegenerative disorders. As a result, tachykinin receptor antagonists are being developed as potential therapeutic agents for these conditions.

Cyclazocine is a synthetic opioid drug that acts as a partial agonist at mu and kappa opioid receptors, and as an antagonist at delta opioid receptors. It has analgesic (pain-relieving) effects, but its use as an analgesic is limited due to its potential for abuse and the occurrence of unpleasant psychotomimetic side effects such as dysphoria, delusions, and hallucinations.

Cyclazocine was first synthesized in 1957 and has been studied for its potential use in the treatment of opioid addiction, but it is not currently approved for medical use in many countries, including the United States. It is classified as a Schedule I controlled substance in the US, indicating that it has a high potential for abuse and no accepted medical use.

Opioid receptors, also known as opiate receptors, are a type of G protein-coupled receptor found in the nervous system and other tissues. They are activated by endogenous opioid peptides, as well as exogenous opiates and opioids. There are several subtypes of opioid receptors, including mu, delta, and kappa.

Kappa opioid receptors (KORs) are a subtype of opioid receptor that are widely distributed throughout the body, including in the brain, spinal cord, and gastrointestinal tract. They are activated by endogenous opioid peptides such as dynorphins, as well as by synthetic and semi-synthetic opioids such as salvinorin A and U-69593.

KORs play a role in the modulation of pain, mood, and addictive behaviors. Activation of KORs has been shown to produce analgesic effects, but can also cause dysphoria, sedation, and hallucinations. KOR agonists have potential therapeutic uses for the treatment of pain, addiction, and other disorders, but their use is limited by their side effects.

It's important to note that opioid receptors and their ligands (drugs or endogenous substances that bind to them) are complex systems with many different actions and effects in the body. The specific effects of KOR activation depend on a variety of factors, including the location and density of the receptors, the presence of other receptors and signaling pathways, and the dose and duration of exposure to the ligand.

Substance P is an undecapeptide neurotransmitter and neuromodulator, belonging to the tachykinin family of peptides. It is widely distributed in the central and peripheral nervous systems and is primarily found in sensory neurons. Substance P plays a crucial role in pain transmission, inflammation, and various autonomic functions. It exerts its effects by binding to neurokinin 1 (NK-1) receptors, which are expressed on the surface of target cells. Apart from nociception and inflammation, Substance P is also involved in regulating emotional behaviors, smooth muscle contraction, and fluid balance.

Neurokinin A (NKA) is a neuropeptide belonging to the tachykinin family, which also includes substance P and neurokinin B. It is widely distributed in the central and peripheral nervous systems and plays a role in various physiological functions such as pain transmission, smooth muscle contraction, and immune response regulation. NKA exerts its effects by binding to neurokinin 1 (NK-1) receptors, although it has lower affinity for these receptors compared to substance P. It is involved in several pathological conditions, including inflammation, neurogenic pain, and neurodegenerative disorders.

Narcotic antagonists are a class of medications that block the effects of opioids, a type of narcotic pain reliever, by binding to opioid receptors in the brain and blocking the activation of these receptors by opioids. This results in the prevention or reversal of opioid-induced effects such as respiratory depression, sedation, and euphoria. Narcotic antagonists are used for a variety of medical purposes, including the treatment of opioid overdose, the management of opioid dependence, and the prevention of opioid-induced side effects in certain clinical situations. Examples of narcotic antagonists include naloxone, naltrexone, and methylnaltrexone.

Morphine is a potent opioid analgesic (pain reliever) derived from the opium poppy. It works by binding to opioid receptors in the brain and spinal cord, blocking the transmission of pain signals and reducing the perception of pain. Morphine is used to treat moderate to severe pain, including pain associated with cancer, myocardial infarction, and other conditions. It can also be used as a sedative and cough suppressant.

Morphine has a high potential for abuse and dependence, and its use should be closely monitored by healthcare professionals. Common side effects of morphine include drowsiness, respiratory depression, constipation, nausea, and vomiting. Overdose can result in respiratory failure, coma, and death.

Neurokinin-2 (NK-2) receptors are a type of G protein-coupled receptor that binds to and is activated by the neuropeptide substance P, which is a member of the tachykinin family. These receptors are widely distributed in the central and peripheral nervous systems and play important roles in various physiological functions, including pain transmission, smooth muscle contraction, and neuroinflammation.

NK-2 receptors are involved in the development of hyperalgesia (an increased sensitivity to pain) and allodynia (pain caused by a stimulus that does not normally provoke pain). They have also been implicated in several pathological conditions, such as inflammatory bowel disease, asthma, and neurodegenerative disorders.

NK-2 receptor antagonists have been developed and investigated for their potential therapeutic use in the treatment of various pain disorders, gastrointestinal diseases, and other medical conditions.

Dynorphins are a type of opioid peptide that is naturally produced in the body. They bind to specific receptors in the brain, known as kappa-opioid receptors, and play a role in modulating pain perception, emotional response, and reward processing. Dynorphins are derived from a larger precursor protein called prodynorphin and are found throughout the nervous system, including in the spinal cord, brainstem, and limbic system. They have been implicated in various physiological processes, as well as in the development of certain neurological and psychiatric disorders, such as chronic pain, depression, and substance use disorders.

Analgesics, opioid are a class of drugs used for the treatment of pain. They work by binding to specific receptors in the brain and spinal cord, blocking the transmission of pain signals to the brain. Opioids can be synthetic or natural, and include drugs such as morphine, codeine, oxycodone, hydrocodone, hydromorphone, fentanyl, and methadone. They are often used for moderate to severe pain, such as that resulting from injury, surgery, or chronic conditions like cancer. However, opioids can also produce euphoria, physical dependence, and addiction, so they are tightly regulated and carry a risk of misuse.

Transfer RNA (tRNA) is a type of RNA molecule that plays a crucial role in protein synthesis. During this process, tRNAs serve as adaptors between the mRNA (messenger RNA) molecules and the amino acids used to construct proteins. Each tRNA contains a specific anticodon sequence that can base-pair with a complementary codon on the mRNA. At the other end of the tRNA, there is a site where an amino acid can attach. This attachment is facilitated by enzymes called aminoacyl tRNA synthetases, which recognize specific tRNAs and catalyze the formation of the ester bond between the tRNA and its cognate amino acid.

Gly (glycine) is one of the 20 standard amino acids found in proteins. It has a simple structure, consisting of an amino group (-NH2), a carboxylic acid group (-COOH), a hydrogen atom (-H), and a side chain made up of a single hydrogen atom (-CH2-). Glycine is the smallest and most flexible of all amino acids due to its lack of a bulky side chain, which allows it to fit into tight spaces within protein structures.

Therefore, 'RNA, Transfer, Gly' can be understood as a transfer RNA (tRNA) molecule specifically responsible for delivering the amino acid glycine (-Gly) during protein synthesis. This tRNA will have an anticodon sequence that base-pairs with the mRNA codons specifying glycine: GGU, GGC, GGA, or GGG.

Carboxypeptidase H is also known as carboxypeptidase E or CPE. It is an enzyme that plays a role in the processing and activation of neuropeptides, which are small protein-like molecules that function as chemical messengers within the nervous system. Carboxypeptidase H/E is responsible for removing certain amino acids from the end of newly synthesized neuropeptides, allowing them to become biologically active. It is widely expressed in the brain and other tissues throughout the body.

Benzomorphans are a class of opioid drugs that have a chemical structure similar to morphine. They are synthetic compounds, meaning they are made in a laboratory and do not occur naturally. Benzomorphans include drugs such as pentazocine and phenazocine, which are used for pain relief and cough suppression. These drugs work by binding to opioid receptors in the brain and spinal cord, which helps to reduce the perception of pain and suppress coughing.

Benzomorphans have a unique chemical structure that differs from other opioids such as morphine or fentanyl. They are classified as "mixed agonist-antagonists," meaning they can act as both an agonist (a substance that binds to a receptor and activates it) and an antagonist (a substance that binds to a receptor but does not activate it, and may block the effects of other substances that do activate the receptor). This property makes benzomorphans useful for pain relief in certain situations, as they can provide pain relief without causing some of the side effects associated with other opioids, such as respiratory depression.

However, like all opioid drugs, benzomorphans carry a risk of addiction and dependence, and can cause serious harm or even death if taken in large doses or mixed with other substances that depress the central nervous system. It is important to use these medications only as directed by a healthcare provider and to follow their instructions carefully.

Benzeneacetamides are a class of organic compounds that consist of a benzene ring, which is a six-carbon cyclic structure with alternating double bonds, linked to an acetamide group. The acetamide group consists of an acetyl functional group (-COCH3) attached to an amide nitrogen (-NH-).

Benzeneacetamides have the general formula C8H9NO, and they can exist in various structural isomers depending on the position of the acetamide group relative to the benzene ring. These compounds are used in the synthesis of pharmaceuticals, dyes, and other chemical products.

In a medical context, some benzeneacetamides have been studied for their potential therapeutic effects. For example, certain derivatives of benzeneacetamide have shown anti-inflammatory, analgesic, and antipyretic properties, making them candidates for the development of new drugs to treat pain and inflammation. However, more research is needed to establish their safety and efficacy in clinical settings.

Naltrexone is a medication that is primarily used to manage alcohol dependence and opioid dependence. It works by blocking the effects of opioids and alcohol on the brain, reducing the euphoric feelings and cravings associated with their use. Naltrexone comes in the form of a tablet that is taken orally, and it has no potential for abuse or dependence.

Medically, naltrexone is classified as an opioid antagonist, which means that it binds to opioid receptors in the brain without activating them, thereby blocking the effects of opioids such as heroin, morphine, and oxycodone. It also reduces the rewarding effects of alcohol by blocking the release of endorphins, which are natural chemicals in the brain that produce feelings of pleasure.

Naltrexone is often used as part of a comprehensive treatment program for addiction, along with counseling, behavioral therapy, and support groups. It can help individuals maintain abstinence from opioids or alcohol by reducing cravings and preventing relapse. Naltrexone is generally safe and well-tolerated, but it may cause side effects such as nausea, headache, dizziness, and fatigue in some people.

It's important to note that naltrexone should only be used under the supervision of a healthcare provider, and it is not recommended for individuals who are currently taking opioids or who have recently stopped using them, as it can cause withdrawal symptoms. Additionally, naltrexone may interact with other medications, so it's important to inform your healthcare provider of all medications you are taking before starting naltrexone therapy.

Beta-endorphins are naturally occurring opioid peptides that are produced in the brain and other parts of the body. They are synthesized from a larger precursor protein called proopiomelanocortin (POMC) and consist of 31 amino acids. Beta-endorphins have potent analgesic effects, which means they can reduce the perception of pain. They also play a role in regulating mood, emotions, and various physiological processes such as immune function and hormonal regulation.

Beta-endorphins bind to opioid receptors in the brain and other tissues, leading to a range of effects including pain relief, sedation, euphoria, and reduced anxiety. They are released in response to stress, physical activity, and certain physiological conditions such as pregnancy and lactation. Beta-endorphins have been studied for their potential therapeutic uses in the treatment of pain, addiction, and mood disorders. However, more research is needed to fully understand their mechanisms of action and potential side effects.

I must clarify that the term "Guinea Pigs" is not typically used in medical definitions. However, in colloquial or informal language, it may refer to people who are used as the first to try out a new medical treatment or drug. This is known as being a "test subject" or "in a clinical trial."

In the field of scientific research, particularly in studies involving animals, guinea pigs are small rodents that are often used as experimental subjects due to their size, cost-effectiveness, and ease of handling. They are not actually pigs from Guinea, despite their name's origins being unclear. However, they do not exactly fit the description of being used in human medical experiments.

Opioid peptides are naturally occurring short chains of amino acids in the body that bind to opioid receptors in the brain, spinal cord, and gut, acting in a similar way to opiate drugs like morphine or heroin. They play crucial roles in pain regulation, reward systems, and addictive behaviors. Some examples of opioid peptides include endorphins, enkephalins, and dynorphins. These substances are released in response to stress, physical exertion, or injury and help modulate the perception of pain and produce feelings of pleasure or euphoria.

Diprenorphine is a potent opioid antagonist, which is used primarily in veterinary medicine as an antidote for overdoses of opioid drugs or accidents involving exposure to opioids in wildlife. It works by blocking the effects of opioids on the brain and reversing their potentially harmful or deadly symptoms, such as respiratory depression, sedation, and decreased heart rate.

Diprenorphine is a non-selective antagonist at mu, delta, and kappa opioid receptors, which means it can reverse the effects of all three types of opioid receptors in the body. It has a high affinity for these receptors, making it a very effective antidote for opioid overdoses.

In human medicine, diprenorphine is not commonly used due to its short duration of action and the availability of other longer-acting opioid antagonists such as naloxone. However, it may be used in some specialized medical settings, such as in the management of opioid toxicity during anesthesia or in cases where a longer-acting antagonist is not available.

It's important to note that diprenorphine should only be administered under the supervision of a trained medical professional, as improper use can lead to serious adverse effects or even death.

Neurokinin-1 (NK-1) receptor antagonists are a class of drugs that block the action of substance P, a neuropeptide involved in pain transmission and inflammation. These drugs work by binding to NK-1 receptors found on nerve cells, preventing substance P from activating them and transmitting pain signals. NK-1 receptor antagonists have been studied for their potential use in treating various conditions associated with pain and inflammation, such as migraine headaches, depression, and irritable bowel syndrome. Some examples of NK-1 receptor antagonists include aprepitant, fosaprepitant, and rolapitant.

Narcotics, in a medical context, are substances that induce sleep, relieve pain, and suppress cough. They are often used for anesthesia during surgical procedures. Narcotics are derived from opium or its synthetic substitutes and include drugs such as morphine, codeine, fentanyl, oxycodone, and hydrocodone. These drugs bind to specific receptors in the brain and spinal cord, reducing the perception of pain and producing a sense of well-being. However, narcotics can also produce physical dependence and addiction, and their long-term use can lead to tolerance, meaning that higher doses are required to achieve the same effect. Narcotics are classified as controlled substances due to their potential for abuse and are subject to strict regulations.

Glycine is a simple amino acid that plays a crucial role in the body. According to the medical definition, glycine is an essential component for the synthesis of proteins, peptides, and other biologically important compounds. It is also involved in various metabolic processes, such as the production of creatine, which supports muscle function, and the regulation of neurotransmitters, affecting nerve impulse transmission and brain function. Glycine can be found as a free form in the body and is also present in many dietary proteins.

Oligopeptides are defined in medicine and biochemistry as short chains of amino acids, typically containing fewer than 20 amino acid residues. These small peptides are important components in various biological processes, such as serving as signaling molecules, enzyme inhibitors, or structural elements in some proteins. They can be found naturally in foods and may also be synthesized for use in medical research and therapeutic applications.

Etorphine is a potent synthetic opioid analgesic drug that is primarily used for the immobilization and veterinary purposes in large animals. It is not commonly used in human medicine due to its high potency and potential for serious side effects, including respiratory depression and death. In medical context, etorphine is classified as a Schedule II controlled substance in the United States, due to its high abuse potential.

Etorphine works by binding to opioid receptors in the brain and spinal cord, which leads to pain relief, sedation, and decreased breathing rate. It is typically administered via injection and its effects can last for several hours. In veterinary medicine, etorphine may be used to immobilize animals such as elephants, rhinos, and large deer species for medical procedures or relocation.

It's important to note that due to its high potency and potential for serious side effects, etorphine should only be administered by trained professionals in a controlled setting.

Thiorphan is not a medical condition or disease, but rather a synthetic medication. It is a potent inhibitor of membrane-bound metalloendopeptidases, also known as neprilysin enzymes. These enzymes are responsible for breaking down certain peptides in the body, including some hormones and neurotransmitters.

Thiorphan has been used in research to study the role of these enzymes in various physiological processes. It is also being investigated as a potential therapeutic agent for conditions such as hypertension, heart failure, and Alzheimer's disease. However, it is not currently approved for clinical use in humans.

Therefore, there is no medical definition of 'Thiorphan' as a condition or disease.

Neurokinin-1 (NK-1) receptors are a type of G protein-coupled receptor that bind to the neuropeptide substance P, which is a member of the tachykinin family. These receptors are widely distributed in the central and peripheral nervous systems and play important roles in various physiological functions, including pain transmission, neuroinflammation, and emesis (vomiting).

NK-1 receptors are activated by substance P, which binds to the receptor's extracellular domain and triggers a signaling cascade that leads to the activation of various intracellular signaling pathways. This activation can ultimately result in the modulation of neuronal excitability, neurotransmitter release, and gene expression.

In addition to their role in normal physiological processes, NK-1 receptors have also been implicated in a number of pathological conditions, including pain, inflammation, and neurodegenerative disorders. As such, NK-1 receptor antagonists have been developed as potential therapeutic agents for the treatment of these conditions.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Protein precursors, also known as proproteins or prohormones, are inactive forms of proteins that undergo post-translational modification to become active. These modifications typically include cleavage of the precursor protein by specific enzymes, resulting in the release of the active protein. This process allows for the regulation and control of protein activity within the body. Protein precursors can be found in various biological processes, including the endocrine system where they serve as inactive hormones that can be converted into their active forms when needed.

Analgesics are a class of drugs that are used to relieve pain. They work by blocking the transmission of pain signals in the nervous system, allowing individuals to manage their pain levels more effectively. There are many different types of analgesics available, including both prescription and over-the-counter options. Some common examples include acetaminophen (Tylenol), ibuprofen (Advil or Motrin), and opioids such as morphine or oxycodone.

The choice of analgesic will depend on several factors, including the type and severity of pain being experienced, any underlying medical conditions, potential drug interactions, and individual patient preferences. It is important to use these medications as directed by a healthcare provider, as misuse or overuse can lead to serious side effects and potential addiction.

In addition to their pain-relieving properties, some analgesics may also have additional benefits such as reducing inflammation (like in the case of nonsteroidal anti-inflammatory drugs or NSAIDs) or causing sedation (as with certain opioids). However, it is essential to weigh these potential benefits against the risks and side effects associated with each medication.

When used appropriately, analgesics can significantly improve a person's quality of life by helping them manage their pain effectively and allowing them to engage in daily activities more comfortably.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

A dose-response relationship in the context of drugs refers to the changes in the effects or symptoms that occur as the dose of a drug is increased or decreased. Generally, as the dose of a drug is increased, the severity or intensity of its effects also increases. Conversely, as the dose is decreased, the effects of the drug become less severe or may disappear altogether.

The dose-response relationship is an important concept in pharmacology and toxicology because it helps to establish the safe and effective dosage range for a drug. By understanding how changes in the dose of a drug affect its therapeutic and adverse effects, healthcare providers can optimize treatment plans for their patients while minimizing the risk of harm.

The dose-response relationship is typically depicted as a curve that shows the relationship between the dose of a drug and its effect. The shape of the curve may vary depending on the drug and the specific effect being measured. Some drugs may have a steep dose-response curve, meaning that small changes in the dose can result in large differences in the effect. Other drugs may have a more gradual dose-response curve, where larger changes in the dose are needed to produce significant effects.

In addition to helping establish safe and effective dosages, the dose-response relationship is also used to evaluate the potential therapeutic benefits and risks of new drugs during clinical trials. By systematically testing different doses of a drug in controlled studies, researchers can identify the optimal dosage range for the drug and assess its safety and efficacy.

Morphinans are a class of organic compounds that share a common skeletal structure, which is based on the morphine molecule. The morphinan structure consists of a tetracyclic ring system made up of three six-membered benzene rings (A, C, and D) fused to a five-membered dihydrofuran ring (B).

Morphinans are important in medicinal chemistry because many opioid analgesics, such as morphine, hydromorphone, oxymorphone, and levorphanol, are derived from or structurally related to morphinans. These compounds exert their pharmacological effects by binding to opioid receptors in the brain and spinal cord, which are involved in pain perception, reward, and addictive behaviors.

It is worth noting that while all opiates (drugs derived from the opium poppy) are morphinans, not all morphinans are opiates. Some synthetic or semi-synthetic morphinans, such as fentanyl and methadone, do not have a natural origin but still share the same basic structure and pharmacological properties.

Tiopronin is a medication that belongs to a class of drugs called mucolytic agents. It works by breaking down mucus in the respiratory tract, making it easier to cough up and clear the airways. Tiopronin is also known as tiopronin sodium or Thiola®.

In addition to its use as a mucolytic agent, tiopronin has been found to be effective in reducing the formation of cystine kidney stones in patients with a rare genetic disorder called cystinuria. It works by binding to cystine in the urine and preventing it from forming into crystals or stones.

Tiopronin is available as a tablet or oral solution and is typically taken several times a day, with dosing adjusted based on the patient's individual needs and response to treatment. Common side effects of tiopronin include stomach upset, loss of appetite, and rash.

Neprilysin (NEP), also known as membrane metallo-endopeptidase or CD10, is a type II transmembrane glycoprotein that functions as a zinc-dependent metalloprotease. It is widely expressed in various tissues, including the kidney, brain, heart, and vasculature. Neprilysin plays a crucial role in the breakdown and regulation of several endogenous bioactive peptides, such as natriuretic peptides, bradykinin, substance P, and angiotensin II. By degrading these peptides, neprilysin helps maintain cardiovascular homeostasis, modulate inflammation, and regulate neurotransmission. In the context of heart failure, neprilysin inhibitors have been developed to increase natriuretic peptide levels, promoting diuresis and vasodilation, ultimately improving cardiac function.

A peptide fragment is a short chain of amino acids that is derived from a larger peptide or protein through various biological or chemical processes. These fragments can result from the natural breakdown of proteins in the body during regular physiological processes, such as digestion, or they can be produced experimentally in a laboratory setting for research or therapeutic purposes.

Peptide fragments are often used in research to map the structure and function of larger peptides and proteins, as well as to study their interactions with other molecules. In some cases, peptide fragments may also have biological activity of their own and can be developed into drugs or diagnostic tools. For example, certain peptide fragments derived from hormones or neurotransmitters may bind to receptors in the body and mimic or block the effects of the full-length molecule.

The adrenal medulla is the inner part of the adrenal gland, which is located on top of the kidneys. It is responsible for producing and releasing hormones such as epinephrine (also known as adrenaline) and norepinephrine (also known as noradrenaline). These hormones play a crucial role in the body's "fight or flight" response, preparing the body for immediate action in response to stress.

Epinephrine increases heart rate, blood pressure, and respiratory rate, while also increasing blood flow to muscles and decreasing blood flow to the skin and digestive system. Norepinephrine has similar effects but is generally less potent than epinephrine. Together, these hormones help to prepare the body for physical activity and increase alertness and focus.

Disorders of the adrenal medulla can lead to a variety of symptoms, including high blood pressure, rapid heart rate, anxiety, and tremors. Some conditions that affect the adrenal medulla include pheochromocytoma, a tumor that causes excessive production of epinephrine and norepinephrine, and neuroblastoma, a cancerous tumor that arises from immature nerve cells in the adrenal gland.

Piperidines are not a medical term per se, but they are a class of organic compounds that have important applications in the pharmaceutical industry. Medically relevant piperidines include various drugs such as some antihistamines, antidepressants, and muscle relaxants.

A piperidine is a heterocyclic amine with a six-membered ring containing five carbon atoms and one nitrogen atom. The structure can be described as a cyclic secondary amine. Piperidines are found in some natural alkaloids, such as those derived from the pepper plant (Piper nigrum), which gives piperidines their name.

In a medical context, it is more common to encounter specific drugs that belong to the class of piperidines rather than the term itself.

In medical terms, the iris refers to the colored portion of the eye that surrounds the pupil. It is a circular structure composed of thin, contractile muscle fibers (radial and circumferential) arranged in a regular pattern. These muscles are controlled by the autonomic nervous system and can adjust the size of the pupil in response to changes in light intensity or emotional arousal. By constricting or dilating the iris, the amount of light entering the eye can be regulated, which helps maintain optimal visual acuity under various lighting conditions.

The color of the iris is determined by the concentration and distribution of melanin pigments within the iris stroma. The iris also contains blood vessels, nerves, and connective tissue that support its structure and function. Anatomically, the iris is continuous with the ciliary body and the choroid, forming part of the uveal tract in the eye.

Alanine is an alpha-amino acid that is used in the biosynthesis of proteins. The molecular formula for alanine is C3H7NO2. It is a non-essential amino acid, which means that it can be produced by the human body through the conversion of other nutrients, such as pyruvate, and does not need to be obtained directly from the diet.

Alanine is classified as an aliphatic amino acid because it contains a simple carbon side chain. It is also a non-polar amino acid, which means that it is hydrophobic and tends to repel water. Alanine plays a role in the metabolism of glucose and helps to regulate blood sugar levels. It is also involved in the transfer of nitrogen between tissues and helps to maintain the balance of nitrogen in the body.

In addition to its role as a building block of proteins, alanine is also used as a neurotransmitter in the brain and has been shown to have a calming effect on the nervous system. It is found in many foods, including meats, poultry, fish, eggs, dairy products, and legumes.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Pyrrolidines are not a medical term per se, but they are a chemical compound that can be encountered in the field of medicine and pharmacology. Pyrrolidine is an organic compound with the molecular formula (CH2)4NH. It is a cyclic secondary amine, which means it contains a nitrogen atom surrounded by four carbon atoms in a ring structure.

Pyrrolidines can be found in certain natural substances and are also synthesized for use in pharmaceuticals and research. They have been used as building blocks in the synthesis of various drugs, including some muscle relaxants, antipsychotics, and antihistamines. Additionally, pyrrolidine derivatives can be found in certain plants and fungi, where they may contribute to biological activity or toxicity.

It is important to note that while pyrrolidines themselves are not a medical condition or diagnosis, understanding their chemical properties and uses can be relevant to the study and development of medications.

Chromaffin granules are membrane-bound organelles found in the cytoplasm of chromaffin cells, which are a type of neuroendocrine cell. These cells are located in the adrenal medulla and some sympathetic ganglia and play a crucial role in the body's stress response.

Chromaffin granules contain a variety of substances, including catecholamines such as epinephrine (adrenaline) and norepinephrine (noradrenaline), as well as proteins and other molecules. When the chromaffin cell is stimulated, the granules fuse with the cell membrane and release their contents into the extracellular space, where they can bind to receptors on nearby cells and trigger a variety of physiological responses.

The name "chromaffin" comes from the fact that these granules contain enzymes that can react with chromium salts to produce a brown color, which is why they are also sometimes referred to as "black-brown granules."

The brain is the central organ of the nervous system, responsible for receiving and processing sensory information, regulating vital functions, and controlling behavior, movement, and cognition. It is divided into several distinct regions, each with specific functions:

1. Cerebrum: The largest part of the brain, responsible for higher cognitive functions such as thinking, learning, memory, language, and perception. It is divided into two hemispheres, each controlling the opposite side of the body.
2. Cerebellum: Located at the back of the brain, it is responsible for coordinating muscle movements, maintaining balance, and fine-tuning motor skills.
3. Brainstem: Connects the cerebrum and cerebellum to the spinal cord, controlling vital functions such as breathing, heart rate, and blood pressure. It also serves as a relay center for sensory information and motor commands between the brain and the rest of the body.
4. Diencephalon: A region that includes the thalamus (a major sensory relay station) and hypothalamus (regulates hormones, temperature, hunger, thirst, and sleep).
5. Limbic system: A group of structures involved in emotional processing, memory formation, and motivation, including the hippocampus, amygdala, and cingulate gyrus.

The brain is composed of billions of interconnected neurons that communicate through electrical and chemical signals. It is protected by the skull and surrounded by three layers of membranes called meninges, as well as cerebrospinal fluid that provides cushioning and nutrients.

The ileum is the third and final segment of the small intestine, located between the jejunum and the cecum (the beginning of the large intestine). It plays a crucial role in nutrient absorption, particularly for vitamin B12 and bile salts. The ileum is characterized by its thin, lined walls and the presence of Peyer's patches, which are part of the immune system and help surveil for pathogens.

Aminolevulinic acid (ALA) is a naturally occurring compound in the human body and is a key precursor in the biosynthesis of heme, which is a component of hemoglobin in red blood cells. It is also used as a photosensitizer in dermatology for the treatment of certain types of skin conditions such as actinic keratosis and basal cell carcinoma.

In medical terms, ALA is classified as an α-keto acid and a porphyrin precursor. It is synthesized in the mitochondria from glycine and succinyl-CoA in a reaction catalyzed by the enzyme aminolevulinic acid synthase. After its synthesis, ALA is transported to the cytosol where it undergoes further metabolism to form porphyrins, which are then used for heme biosynthesis in the mitochondria.

In dermatology, topical application of ALA followed by exposure to a specific wavelength of light can lead to the production of reactive oxygen species that destroy abnormal cells in the skin while leaving healthy cells unharmed. This makes it an effective treatment for precancerous and cancerous lesions on the skin.

It is important to note that ALA can cause photosensitivity, which means that patients who have undergone ALA-based treatments should avoid exposure to sunlight or other sources of bright light for a period of time after the treatment to prevent adverse reactions.

Somatostatin is a hormone that inhibits the release of several hormones and also has a role in slowing down digestion. It is produced by the body in various parts of the body, including the hypothalamus (a part of the brain), the pancreas, and the gastrointestinal tract.

Somatostatin exists in two forms: somatostatin-14 and somatostatin-28, which differ in their length. Somatostatin-14 is the predominant form found in the brain, while somatostatin-28 is the major form found in the gastrointestinal tract.

Somatostatin has a wide range of effects on various physiological processes, including:

* Inhibiting the release of several hormones such as growth hormone, insulin, glucagon, and gastrin
* Slowing down digestion by inhibiting the release of digestive enzymes from the pancreas and reducing blood flow to the gastrointestinal tract
* Regulating neurotransmission in the brain

Somatostatin is used clinically as a diagnostic tool for detecting certain types of tumors that overproduce growth hormone or other hormones, and it is also used as a treatment for some conditions such as acromegaly (a condition characterized by excessive growth hormone production) and gastrointestinal disorders.

The Globus Pallidus is a structure in the brain that is part of the basal ganglia, a group of nuclei associated with movement control and other functions. It has two main subdivisions: the external (GPe) and internal (GPi) segments. The GPe receives input from the striatum and sends inhibitory projections to the subthalamic nucleus, while the GPi sends inhibitory projections to the thalamus, which in turn projects to the cerebral cortex. These connections allow for the regulation of motor activity, with abnormal functioning of the Globus Pallidus being implicated in various movement disorders such as Parkinson's disease and Huntington's disease.

Site-directed mutagenesis is a molecular biology technique used to introduce specific and targeted changes to a specific DNA sequence. This process involves creating a new variant of a gene or a specific region of interest within a DNA molecule by introducing a planned, deliberate change, or mutation, at a predetermined site within the DNA sequence.

The methodology typically involves the use of molecular tools such as PCR (polymerase chain reaction), restriction enzymes, and/or ligases to introduce the desired mutation(s) into a plasmid or other vector containing the target DNA sequence. The resulting modified DNA molecule can then be used to transform host cells, allowing for the production of large quantities of the mutated gene or protein for further study.

Site-directed mutagenesis is a valuable tool in basic research, drug discovery, and biotechnology applications where specific changes to a DNA sequence are required to understand gene function, investigate protein structure/function relationships, or engineer novel biological properties into existing genes or proteins.

Drug tolerance is a medical concept that refers to the decreased response to a drug following its repeated use, requiring higher doses to achieve the same effect. This occurs because the body adapts to the presence of the drug, leading to changes in the function or expression of targets that the drug acts upon, such as receptors or enzymes. Tolerance can develop to various types of drugs, including opioids, benzodiazepines, and alcohol, and it is often associated with physical dependence and addiction. It's important to note that tolerance is different from resistance, which refers to the ability of a pathogen to survive or grow in the presence of a drug, such as antibiotics.

Dihydromorphine is a semi-synthetic opioid agonist that is derived from morphine, which is a natural opiate alkaloid found in the poppy plant (Papaver somniferum). It is a potent analgesic drug used to treat moderate to severe pain. Dihydromorphine works by binding to and activating the mu-opioid receptors in the brain and spinal cord, which inhibits the transmission of pain signals and produces a subjective feeling of euphoria or pleasure.

Dihydromorphine is similar in structure and effects to other opioids such as heroin, oxycodone, and hydromorphone. It has a rapid onset of action and can produce strong analgesic effects, but it also carries a high risk of dependence, addiction, and respiratory depression, which can be fatal if not treated promptly.

Dihydromorphine is available in various forms, including tablets, injectable solutions, and suppositories. It is primarily used in Europe and Asia for the treatment of pain, although it has been largely replaced by other opioids such as morphine and fentanyl in many countries due to its higher abuse potential and narrower therapeutic index.

An amino acid substitution is a type of mutation in which one amino acid in a protein is replaced by another. This occurs when there is a change in the DNA sequence that codes for a particular amino acid in a protein. The genetic code is redundant, meaning that most amino acids are encoded by more than one codon (a sequence of three nucleotides). As a result, a single base pair change in the DNA sequence may not necessarily lead to an amino acid substitution. However, if a change does occur, it can have a variety of effects on the protein's structure and function, depending on the nature of the substituted amino acids. Some substitutions may be harmless, while others may alter the protein's activity or stability, leading to disease.

A Structure-Activity Relationship (SAR) in the context of medicinal chemistry and pharmacology refers to the relationship between the chemical structure of a drug or molecule and its biological activity or effect on a target protein, cell, or organism. SAR studies aim to identify patterns and correlations between structural features of a compound and its ability to interact with a specific biological target, leading to a desired therapeutic response or undesired side effects.

By analyzing the SAR, researchers can optimize the chemical structure of lead compounds to enhance their potency, selectivity, safety, and pharmacokinetic properties, ultimately guiding the design and development of novel drugs with improved efficacy and reduced toxicity.

The vas deferens is a muscular tube that carries sperm from the epididymis to the urethra during ejaculation in males. It is a part of the male reproductive system and is often targeted in surgical procedures like vasectomy, which is a form of permanent birth control.

Peptides are short chains of amino acid residues linked by covalent bonds, known as peptide bonds. They are formed when two or more amino acids are joined together through a condensation reaction, which results in the elimination of a water molecule and the formation of an amide bond between the carboxyl group of one amino acid and the amino group of another.

Peptides can vary in length from two to about fifty amino acids, and they are often classified based on their size. For example, dipeptides contain two amino acids, tripeptides contain three, and so on. Oligopeptides typically contain up to ten amino acids, while polypeptides can contain dozens or even hundreds of amino acids.

Peptides play many important roles in the body, including serving as hormones, neurotransmitters, enzymes, and antibiotics. They are also used in medical research and therapeutic applications, such as drug delivery and tissue engineering.

"Inbred strains of rats" are genetically identical rodents that have been produced through many generations of brother-sister mating. This results in a high degree of homozygosity, where the genes at any particular locus in the genome are identical in all members of the strain.

Inbred strains of rats are widely used in biomedical research because they provide a consistent and reproducible genetic background for studying various biological phenomena, including the effects of drugs, environmental factors, and genetic mutations on health and disease. Additionally, inbred strains can be used to create genetically modified models of human diseases by introducing specific mutations into their genomes.

Some commonly used inbred strains of rats include the Wistar Kyoto (WKY), Sprague-Dawley (SD), and Fischer 344 (F344) rat strains. Each strain has its own unique genetic characteristics, making them suitable for different types of research.

Carboxypeptidases are a group of enzymes that catalyze the cleavage of peptide bonds at the carboxyl-terminal end of polypeptides or proteins. They specifically remove the last amino acid residue from the protein chain, provided that it has a free carboxyl group and is not blocked by another chemical group. Carboxypeptidases are classified into two main types based on their catalytic mechanism: serine carboxypeptidases and metallo-carboxypeptidases.

Serine carboxypeptidases, also known as chymotrypsin C or carboxypeptidase C, use a serine residue in their active site to catalyze the hydrolysis of peptide bonds. They are found in various organisms, including animals and bacteria.

Metallo-carboxypeptidases, on the other hand, require a metal ion (usually zinc) for their catalytic activity. They can be further divided into several subtypes based on their structure and substrate specificity. For example, carboxypeptidase A prefers to cleave hydrophobic amino acids from the carboxyl-terminal end of proteins, while carboxypeptidase B specifically removes basic residues (lysine or arginine).

Carboxypeptidases have important roles in various biological processes, such as protein maturation, digestion, and regulation of blood pressure. Dysregulation of these enzymes has been implicated in several diseases, including cancer, neurodegenerative disorders, and cardiovascular disease.

"Competitive binding" is a term used in pharmacology and biochemistry to describe the behavior of two or more molecules (ligands) competing for the same binding site on a target protein or receptor. In this context, "binding" refers to the physical interaction between a ligand and its target.

When a ligand binds to a receptor, it can alter the receptor's function, either activating or inhibiting it. If multiple ligands compete for the same binding site, they will compete to bind to the receptor. The ability of each ligand to bind to the receptor is influenced by its affinity for the receptor, which is a measure of how strongly and specifically the ligand binds to the receptor.

In competitive binding, if one ligand is present in high concentrations, it can prevent other ligands with lower affinity from binding to the receptor. This is because the higher-affinity ligand will have a greater probability of occupying the binding site and blocking access to the other ligands. The competition between ligands can be described mathematically using equations such as the Langmuir isotherm, which describes the relationship between the concentration of ligand and the fraction of receptors that are occupied by the ligand.

Competitive binding is an important concept in drug development, as it can be used to predict how different drugs will interact with their targets and how they may affect each other's activity. By understanding the competitive binding properties of a drug, researchers can optimize its dosage and delivery to maximize its therapeutic effect while minimizing unwanted side effects.

Molecular models are three-dimensional representations of molecular structures that are used in the field of molecular biology and chemistry to visualize and understand the spatial arrangement of atoms and bonds within a molecule. These models can be physical or computer-generated and allow researchers to study the shape, size, and behavior of molecules, which is crucial for understanding their function and interactions with other molecules.

Physical molecular models are often made up of balls (representing atoms) connected by rods or sticks (representing bonds). These models can be constructed manually using materials such as plastic or wooden balls and rods, or they can be created using 3D printing technology.

Computer-generated molecular models, on the other hand, are created using specialized software that allows researchers to visualize and manipulate molecular structures in three dimensions. These models can be used to simulate molecular interactions, predict molecular behavior, and design new drugs or chemicals with specific properties. Overall, molecular models play a critical role in advancing our understanding of molecular structures and their functions.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

Benzamides are a class of organic compounds that consist of a benzene ring (a aromatic hydrocarbon) attached to an amide functional group. The amide group can be bound to various substituents, leading to a variety of benzamide derivatives with different biological activities.

In a medical context, some benzamides have been developed as drugs for the treatment of various conditions. For example, danzol (a benzamide derivative) is used as a hormonal therapy for endometriosis and breast cancer. Additionally, other benzamides such as sulpiride and amisulpride are used as antipsychotic medications for the treatment of schizophrenia and related disorders.

It's important to note that while some benzamides have therapeutic uses, others may be toxic or have adverse effects, so they should only be used under the supervision of a medical professional.

Protein conformation refers to the specific three-dimensional shape that a protein molecule assumes due to the spatial arrangement of its constituent amino acid residues and their associated chemical groups. This complex structure is determined by several factors, including covalent bonds (disulfide bridges), hydrogen bonds, van der Waals forces, and ionic bonds, which help stabilize the protein's unique conformation.

Protein conformations can be broadly classified into two categories: primary, secondary, tertiary, and quaternary structures. The primary structure represents the linear sequence of amino acids in a polypeptide chain. The secondary structure arises from local interactions between adjacent amino acid residues, leading to the formation of recurring motifs such as α-helices and β-sheets. Tertiary structure refers to the overall three-dimensional folding pattern of a single polypeptide chain, while quaternary structure describes the spatial arrangement of multiple folded polypeptide chains (subunits) that interact to form a functional protein complex.

Understanding protein conformation is crucial for elucidating protein function, as the specific three-dimensional shape of a protein directly influences its ability to interact with other molecules, such as ligands, nucleic acids, or other proteins. Any alterations in protein conformation due to genetic mutations, environmental factors, or chemical modifications can lead to loss of function, misfolding, aggregation, and disease states like neurodegenerative disorders and cancer.

Intraventricular injections are a type of medical procedure where medication is administered directly into the cerebral ventricles of the brain. The cerebral ventricles are fluid-filled spaces within the brain that contain cerebrospinal fluid (CSF). This procedure is typically used to deliver drugs that target conditions affecting the central nervous system, such as infections or tumors.

Intraventricular injections are usually performed using a thin, hollow needle that is inserted through a small hole drilled into the skull. The medication is then injected directly into the ventricles, allowing it to circulate throughout the CSF and reach the brain tissue more efficiently than other routes of administration.

This type of injection is typically reserved for situations where other methods of drug delivery are not effective or feasible. It carries a higher risk of complications, such as bleeding, infection, or damage to surrounding tissues, compared to other routes of administration. Therefore, it is usually performed by trained medical professionals in a controlled clinical setting.

Spinal injections, also known as epidural injections or intrathecal injections, are medical procedures involving the injection of medications directly into the spinal canal. The medication is usually delivered into the space surrounding the spinal cord (the epidural space) or into the cerebrospinal fluid that surrounds and protects the spinal cord (the subarachnoid space).

The medications used in spinal injections can include local anesthetics, steroids, opioids, or a combination of these. The purpose of spinal injections is to provide diagnostic information, therapeutic relief, or both. They are commonly used to treat various conditions affecting the spine, such as radicular pain (pain that radiates down the arms or legs), disc herniation, spinal stenosis, and degenerative disc disease.

Spinal injections can be administered using different techniques, including fluoroscopy-guided injections, computed tomography (CT) scan-guided injections, or with the help of a nerve stimulator. These techniques ensure accurate placement of the medication and minimize the risk of complications.

It is essential to consult a healthcare professional for specific information regarding spinal injections and their potential benefits and risks.

The corpus striatum is a part of the brain that plays a crucial role in movement, learning, and cognition. It consists of two structures called the caudate nucleus and the putamen, which are surrounded by the external and internal segments of the globus pallidus. Together, these structures form the basal ganglia, a group of interconnected neurons that help regulate voluntary movement.

The corpus striatum receives input from various parts of the brain, including the cerebral cortex, thalamus, and other brainstem nuclei. It processes this information and sends output to the globus pallidus and substantia nigra, which then project to the thalamus and back to the cerebral cortex. This feedback loop helps coordinate and fine-tune movements, allowing for smooth and coordinated actions.

Damage to the corpus striatum can result in movement disorders such as Parkinson's disease, Huntington's disease, and dystonia. These conditions are characterized by abnormal involuntary movements, muscle stiffness, and difficulty initiating or controlling voluntary movements.

Benzylidene compounds are organic chemical compounds that contain a benzylidene group, which is a functional group consisting of a carbon atom double-bonded to a carbonyl group and single-bonded to a phenyl ring. The general structure of a benzylidene compound can be represented as R-CH=C(Ph)-O-, where R is an organic residue and Ph represents the phenyl group.

These compounds are known for their wide range of applications in various fields, including pharmaceuticals, agrochemicals, dyes, and perfumes. Some benzylidene compounds exhibit biological activities, such as anti-inflammatory, antimicrobial, and anticancer properties, making them valuable candidates for drug development.

It is important to note that the term 'benzylidene' refers only to the functional group and not to a specific class of compounds. Therefore, there are many different types of benzylidene compounds with varying chemical structures and properties.

The myenteric plexus, also known as Auerbach's plexus, is a component of the enteric nervous system located in the wall of the gastrointestinal tract. It is a network of nerve cells (neurons) and supporting cells (neuroglia) that lies between the inner circular layer and outer longitudinal muscle layers of the digestive system's muscularis externa.

The myenteric plexus plays a crucial role in controlling gastrointestinal motility, secretion, and blood flow, primarily through its intrinsic nerve circuits called reflex arcs. These reflex arcs regulate peristalsis (the coordinated muscle contractions that move food through the digestive tract) and segmentation (localized contractions that mix and churn the contents within a specific region of the gut).

Additionally, the myenteric plexus receives input from both the sympathetic and parasympathetic divisions of the autonomic nervous system, allowing for central nervous system regulation of gastrointestinal functions. Dysfunction in the myenteric plexus has been implicated in various gastrointestinal disorders, such as irritable bowel syndrome, achalasia, and intestinal pseudo-obstruction.

The locus coeruleus (LC) is a small nucleus in the brainstem, specifically located in the rostral pons and dorsal to the fourth ventricle. It is the primary site of noradrenaline (norepinephrine) synthesis, storage, and release in the central nervous system. The LC projects its neuronal fibers widely throughout the brain, including the cerebral cortex, thalamus, hippocampus, amygdala, and spinal cord. It plays a crucial role in various physiological functions such as arousal, attention, learning, memory, stress response, and regulation of the sleep-wake cycle. The LC's activity is associated with several neurological and psychiatric conditions, including anxiety disorders, depression, post-traumatic stress disorder (PTSD), and neurodegenerative diseases like Parkinson's and Alzheimer's disease.

Neurons, also known as nerve cells or neurocytes, are specialized cells that constitute the basic unit of the nervous system. They are responsible for receiving, processing, and transmitting information and signals within the body. Neurons have three main parts: the dendrites, the cell body (soma), and the axon. The dendrites receive signals from other neurons or sensory receptors, while the axon transmits these signals to other neurons, muscles, or glands. The junction between two neurons is called a synapse, where neurotransmitters are released to transmit the signal across the gap (synaptic cleft) to the next neuron. Neurons vary in size, shape, and structure depending on their function and location within the nervous system.

In the context of medical and biological sciences, a "binding site" refers to a specific location on a protein, molecule, or cell where another molecule can attach or bind. This binding interaction can lead to various functional changes in the original protein or molecule. The other molecule that binds to the binding site is often referred to as a ligand, which can be a small molecule, ion, or even another protein.

The binding between a ligand and its target binding site can be specific and selective, meaning that only certain ligands can bind to particular binding sites with high affinity. This specificity plays a crucial role in various biological processes, such as signal transduction, enzyme catalysis, or drug action.

In the case of drug development, understanding the location and properties of binding sites on target proteins is essential for designing drugs that can selectively bind to these sites and modulate protein function. This knowledge can help create more effective and safer therapeutic options for various diseases.

Protease inhibitors are a class of antiviral drugs that are used to treat infections caused by retroviruses, such as the human immunodeficiency virus (HIV), which is responsible for causing AIDS. These drugs work by blocking the activity of protease enzymes, which are necessary for the replication and multiplication of the virus within infected cells.

Protease enzymes play a crucial role in the life cycle of retroviruses by cleaving viral polyproteins into functional units that are required for the assembly of new viral particles. By inhibiting the activity of these enzymes, protease inhibitors prevent the virus from replicating and spreading to other cells, thereby slowing down the progression of the infection.

Protease inhibitors are often used in combination with other antiretroviral drugs as part of highly active antiretroviral therapy (HAART) for the treatment of HIV/AIDS. Common examples of protease inhibitors include saquinavir, ritonavir, indinavir, and atazanavir. While these drugs have been successful in improving the outcomes of people living with HIV/AIDS, they can also cause side effects such as nausea, diarrhea, headaches, and lipodystrophy (changes in body fat distribution).

Neurotransmitter agents are substances that affect the synthesis, storage, release, uptake, degradation, or reuptake of neurotransmitters, which are chemical messengers that transmit signals across a chemical synapse from one neuron to another. These agents can be either agonists, which mimic the action of a neurotransmitter and bind to its receptor, or antagonists, which block the action of a neurotransmitter by binding to its receptor without activating it. They are used in medicine to treat various neurological and psychiatric disorders, such as depression, anxiety, and Parkinson's disease.

Morphine derivatives are substances that are synthesized from or structurally similar to morphine, a natural opiate alkaloid found in the opium poppy. These compounds share many of the same pharmacological properties as morphine and are often used for their analgesic (pain-relieving), sedative, and anxiolytic (anxiety-reducing) effects.

Examples of morphine derivatives include:

1. Hydrocodone: A semi-synthetic opioid that is often combined with acetaminophen for the treatment of moderate to severe pain.
2. Oxycodone: A synthetic opioid that is used for the management of moderate to severe pain, either alone or in combination with other medications.
3. Hydromorphone: A potent semi-synthetic opioid that is used for the treatment of severe pain, typically in a hospital setting.
4. Oxymorphone: A synthetic opioid that is similar to hydromorphone in its potency and use for managing severe pain.
5. Codeine: A naturally occurring opiate alkaloid that is less potent than morphine but still has analgesic, cough suppressant, and antidiarrheal properties. It is often combined with other medications for various therapeutic purposes.
6. Fentanyl: A synthetic opioid that is significantly more potent than morphine and is used for the management of severe pain, typically in a hospital or clinical setting.

It's important to note that while these derivatives can be beneficial for managing pain and other symptoms, they also carry a risk of dependence, addiction, and potentially life-threatening side effects such as respiratory depression. As a result, their use should be closely monitored by healthcare professionals and prescribed cautiously.

Neuroblastoma is defined as a type of cancer that develops from immature nerve cells found in the fetal or early postnatal period, called neuroblasts. It typically occurs in infants and young children, with around 90% of cases diagnosed before age five. The tumors often originate in the adrenal glands but can also arise in the neck, chest, abdomen, or spine. Neuroblastoma is characterized by its ability to spread (metastasize) to other parts of the body, including bones, bone marrow, lymph nodes, and skin. The severity and prognosis of neuroblastoma can vary widely, depending on factors such as the patient's age at diagnosis, stage of the disease, and specific genetic features of the tumor.

"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

A radioligand assay is a type of in vitro binding assay used in molecular biology and pharmacology to measure the affinity and quantity of a ligand (such as a drug or hormone) to its specific receptor. In this technique, a small amount of a radioactively labeled ligand, also known as a radioligand, is introduced to a sample containing the receptor of interest. The radioligand binds competitively with other unlabeled ligands present in the sample for the same binding site on the receptor. After allowing sufficient time for binding, the reaction is stopped, and the amount of bound radioligand is measured using a technique such as scintillation counting. The data obtained from this assay can be used to determine the dissociation constant (Kd) and maximum binding capacity (Bmax) of the receptor-ligand interaction, which are important parameters in understanding the pharmacological properties of drugs and other ligands.

The spinal cord is a major part of the nervous system, extending from the brainstem and continuing down to the lower back. It is a slender, tubular bundle of nerve fibers (axons) and support cells (glial cells) that carries signals between the brain and the rest of the body. The spinal cord primarily serves as a conduit for motor information, which travels from the brain to the muscles, and sensory information, which travels from the body to the brain. It also contains neurons that can independently process and respond to information within the spinal cord without direct input from the brain.

The spinal cord is protected by the bony vertebral column (spine) and is divided into 31 segments: 8 cervical, 12 thoracic, 5 lumbar, 5 sacral, and 1 coccygeal. Each segment corresponds to a specific region of the body and gives rise to pairs of spinal nerves that exit through the intervertebral foramina at each level.

The spinal cord is responsible for several vital functions, including:

1. Reflexes: Simple reflex actions, such as the withdrawal reflex when touching a hot surface, are mediated by the spinal cord without involving the brain.
2. Muscle control: The spinal cord carries motor signals from the brain to the muscles, enabling voluntary movement and muscle tone regulation.
3. Sensory perception: The spinal cord transmits sensory information, such as touch, temperature, pain, and vibration, from the body to the brain for processing and awareness.
4. Autonomic functions: The sympathetic and parasympathetic divisions of the autonomic nervous system originate in the thoracolumbar and sacral regions of the spinal cord, respectively, controlling involuntary physiological responses like heart rate, blood pressure, digestion, and respiration.

Damage to the spinal cord can result in various degrees of paralysis or loss of sensation below the level of injury, depending on the severity and location of the damage.

Galanin is a neuropeptide, which is a type of small protein molecule that functions as a neurotransmitter or neuromodulator in the nervous system. It is widely distributed throughout the central and peripheral nervous systems of vertebrates and plays important roles in various physiological functions, including modulation of pain perception, regulation of feeding behavior, control of circadian rhythms, and cognitive processes such as learning and memory.

Galanin is synthesized from a larger precursor protein called preprogalanin, which is cleaved into several smaller peptides, including galanin itself, galanin message-associated peptide (GMAP), and alarin. Galanin exerts its effects by binding to specific G protein-coupled receptors, known as the galanin receptor family, which includes three subtypes: GalR1, GalR2, and GalR3. These receptors are widely expressed in various tissues and organs, including the brain, spinal cord, gastrointestinal tract, pancreas, and cardiovascular system.

Galanin has been implicated in several pathological conditions, such as chronic pain, depression, anxiety, epilepsy, and neurodegenerative disorders like Alzheimer's disease and Parkinson's disease. As a result, there is ongoing research into the development of galanin-based therapies for these conditions.

... enkephalins MeSH D12.776.641.650.575.281.075 - enkephalin, ala(2)-mephe(4)-gly(5)- MeSH D12.776.641.650.575.281.231 - ... enkephalin, leucine MeSH D12.776.641.650.575.281.381 - enkephalin, methionine MeSH D12.776.641.650.575.281.600 - enkephalin, d- ... 5)- MeSH D12.776.641.650.800.354 - eledoisin MeSH D12.776.641.650.800.475 - kassinin MeSH D12.776.641.650.800.500 - neurokinin ...
... enkephalins MeSH D12.644.468.281.075 - enkephalin, ala(2)-mephe(4)-gly(5)- MeSH D12.644.468.281.231 - enkephalin, leucine MeSH ... mephe(4),met(0)-ol-enkephalin MeSH D12.644.468.281.600 - enkephalin, d-penicillamine (2,5)- MeSH D12.644.548.009 - activins ... gly(5)- MeSH D12.644.400.575.281.231 - enkephalin, leucine MeSH D12.644.400.575.281.381 - enkephalin, methionine MeSH D12.644. ... enkephalins MeSH D12.644.400.575.281.075 - enkephalin, ala(2)-mephe(4)- ...
Its structure is H-Tyr-D-Ala-Gly-N-MePhe-Gly-ol. DAMGO has been used in experimental settings for the possibility of ... DAMGO ([D-Ala2, N-MePhe4, Gly-ol]-enkephalin) is a synthetic opioid peptide with high μ-opioid receptor specificity. It was ... Koehl A, Hu H, Maeda S, Zhang Y, Qu Q, Paggi JM, et al. (June 2018). "Structure of the µ-opioid receptor-Gi". Nature. 558 (7711 ... 32 (5): 829-839. doi:10.1016/S0896-6273(01)00517-7. PMID 11738029. S2CID 16396686. He L, Fong J, von Zastrow M, Whistler JL ( ...
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology * Male * Narcotic Antagonists / pharmacology ... MePhe(4)-Gly(5)- * Somatostatin Grants and funding * GM-58905/GM/NIGMS NIH HHS/United States ... enkephalin (DAMGO) and a mu specific antagonist, D-Phe-Cys-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP) on cardiovascular responses in ... enkephalin (DAMGO) and a mu specific ant … ...
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- Grants and funding * Australian Postgraduate Award/International ... MePhe(4)-Gly(5)- / pharmacology * Periaqueductal Gray* * Rats * Rats, Sprague-Dawley ...
... enkephalins MeSH D12.776.641.650.575.281.075 - enkephalin, ala(2)-mephe(4)-gly(5)- MeSH D12.776.641.650.575.281.231 - ... enkephalin, leucine MeSH D12.776.641.650.575.281.381 - enkephalin, methionine MeSH D12.776.641.650.575.281.600 - enkephalin, d- ... 5)- MeSH D12.776.641.650.800.354 - eledoisin MeSH D12.776.641.650.800.475 - kassinin MeSH D12.776.641.650.800.500 - neurokinin ...
Bailey CP, Oldfield S, Llorente J, Caunt CJ, Teschemacher AG, Roberts L et al. Involvement of PKCα and G-protein-coupled ... MePhe(4)-Gly(5)-enkephalin Medicine & Life Sciences 46% * Neurons Medicine & Life Sciences 39% ... Bailey, Christopher P ; Oldfield, S ; Llorente, J et al. / Involvement of PKCα and G-protein-coupled receptor kinase 2 in ... J et al. In: British Journal of Pharmacology, Vol. 158, No. 1, 09.2009, p. 157-164.. Research output: Contribution to journal ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-. ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA. ... ENKEPHALIN, D-PENICILLAMINE (2,5)-. D-PENICILINA (2,5)-ENCEFALINA. ENCEFALITIS LIMBICA. LIMBIC ENCEPHALITIS. ENCEFALITE LÍMBICA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS. FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO. GUANINE NUCLEOTIDE-RELEASING FACTOR 2. FATOR 2 DE ... FACTOR 2 DE ELONGACION PEPTIDA. PEPTIDE ELONGATION FACTOR 2. ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-. ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA. ... ENKEPHALIN, D-PENICILLAMINE (2,5)-. D-PENICILINA (2,5)-ENCEFALINA. ENCEFALITIS LIMBICA. LIMBIC ENCEPHALITIS. ENCEFALITE LÍMBICA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS. FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO. GUANINE NUCLEOTIDE-RELEASING FACTOR 2. FATOR 2 DE ... FACTOR 2 DE ELONGACION PEPTIDA. PEPTIDE ELONGATION FACTOR 2. ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-. ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA. ... ENKEPHALIN, D-PENICILLAMINE (2,5)-. D-PENICILINA (2,5)-ENCEFALINA. ENCEFALITIS LIMBICA. LIMBIC ENCEPHALITIS. ENCEFALITE LÍMBICA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS. FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO. GUANINE NUCLEOTIDE-RELEASING FACTOR 2. FATOR 2 DE ... FACTOR 2 DE ELONGACION PEPTIDA. PEPTIDE ELONGATION FACTOR 2. ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA ... ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) D-PENICILINA (2,5)-ENCEFALINA ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR G FACTOR G DE ELONGACION PEPTIDA ... GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA ... ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) D-PENICILINA (2,5)-ENCEFALINA ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR G FACTOR G DE ELONGACION PEPTIDA ... GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ... MEPHE(4)-GLY(5)-ENCEFALINA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR 2 ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 ... D-PENICILINA (2,5)-ENCEFALINA ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-. ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA. ... ENKEPHALIN, D-PENICILLAMINE (2,5)-. D-PENICILINA (2,5)-ENCEFALINA. ENCEFALITIS LIMBICA. LIMBIC ENCEPHALITIS. ENCEFALITE LÍMBICA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS. FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO. GUANINE NUCLEOTIDE-RELEASING FACTOR 2. FATOR 2 DE ... FACTOR 2 DE ELONGACION PEPTIDA. PEPTIDE ELONGATION FACTOR 2. ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA ... ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) D-PENICILINA (2,5)-ENCEFALINA ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR G FACTOR G DE ELONGACION PEPTIDA ... GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ... MEPHE(4)-GLY(5)-ENCEFALINA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR 2 ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 ... D-PENICILINA (2,5)-ENCEFALINA ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA ... ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) D-PENICILINA (2,5)-ENCEFALINA ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR G FACTOR G DE ELONGACION PEPTIDA ... GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ALA(2)-MEPHE(4)-GLY(5)-ENCEFALINA ... ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) D-PENICILINA (2,5)-ENCEFALINA ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR G FACTOR G DE ELONGACION PEPTIDA ... GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 LIBERADOR DE GUANINA NUCLEOTIDO FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA ...
ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)- ENCEFALINA ALA(2)-MEFE(4)-GLI(5) ... MEPHE(4)-GLY(5)-ENCEFALINA ... FATOR 2 DE ELONGAÇÃO DE PEPTÍDIOS PEPTIDE ELONGATION FACTOR 2 ... FACTOR 2 DE ELONGACION PEPTIDA FATOR 2 DE LIBERAÇÃO DO NUCLEOTÍDIO GUANINA GUANINE NUCLEOTIDE-RELEASING FACTOR 2 FACTOR 2 ... D-PENICILINA (2,5)-ENCEFALINA ENKEPHALIN, D-PENICILLAMINE (2,5)- ENCEFALINA D-PENICILAMINA (2,5) ...
DAGO ([D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin), a specific μ agonist, evoked a significant dose-dependent (10-7-10-5 M) ... DAGO ([D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin), a specific μ agonist, evoked a significant dose-dependent (10-7-10-5 M) ... MePhe(4)-Gly(5)-enkephalin Medicine & Life Sciences 60% * Opioid Analgesics Medicine & Life Sciences 43% ... DAGO ([D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin), a specific μ agonist, evoked a significant dose-dependent (10-7-10-5 M) ...
This presynaptic inhibitory action was mimicked by [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (0.1 μM) and the analgesic dipeptide ... This presynaptic inhibitory action was mimicked by [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (0.1 μM) and the analgesic dipeptide ... This presynaptic inhibitory action was mimicked by [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (0.1 μM) and the analgesic dipeptide ... This presynaptic inhibitory action was mimicked by [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (0.1 μM) and the analgesic dipeptide ...
The μ-opioid receptor (MOP-R) agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) also produced dose-dependent flexor ... The μ-opioid receptor (MOP-R) agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) also produced dose-dependent flexor ... Ono, Takeshi ; Inoue, Makoto ; Harunor Rashid, M. et al. / Stimulation of peripheral nociceptor endings by low dose morphine ... The μ-opioid receptor (MOP-R) agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) also produced dose-dependent flexor ...
Ko, M. C.Holden ; Song, M. S. ; Edwards, T. et al. / The role of central μ opioid receptors in opioid-induced itch in primates ... Intrathecal (i.t.) administration of peptidic MOR agonist [D-Ala2, N-Me-Phe 4,Gly5-ol]-enkephalin (DAMGO, 0.00032-0.01 mg) ... Gly5-ol]-enkephalin (DAMGO, 0.00032-0.01 mg) evoked scratching, but i.v, DAMGO (0.01-1 mg/kg) did not increase scratching. A ... enkephalin (DAMGO, 0.00032-0.01 mg) evoked scratching, but i.v, DAMGO (0.01-1 mg/kg) did not increase scratching. A similar ...
intra-nac treatment with the selective μ-opioid receptor agonist [d-ala(2),n-mephe(4),gly(5)-ol]enkephalin (damgo) (0.1-10 ng) ... intra-nac treatment with β-endorphin (0.01-1 μg) increased social play, but met-enkephalin (0.1-5 μg) and the enkephalinase ... enkephalin) (0.3-3 μg) had no effects, whereas the κ-opioid receptor agonist u69593 (n-methyl-2-phenyl-n-[(5r,7s,8s)-7-( ... simon et al 1979) and certainly spare the rewarding effects of apomorphine (roberts & vickers 1988). it is clear that reward ...
Microinjection of the µ receptor agonist [D-Ala(2) , MePhe(4) , Gly(5) -ol]-enkephalin (DAMGO), but not that of the α2A - ... BACKGROUND AND PURPOSE: µ-Opioid receptors, pro-opiomelanocortin and pro-enkephalin are highly expressed in the nucleus tractus ... MePhe(4)-Gly(5)-Encefalina/administração & dosagem , Ala(2)-MePhe(4)-Gly(5)-Encefalina/farmacologia , Hipertensão/induzido ... 2. Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national ...
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- D12.776.641.650.575.281.75 D12.776.631.650.575.281.75 Enkephalin, D-Penicillamine (2,5)- ... MePhe(4),Met(0)-ol-enkephalin D12.776.641.650.575.281.381.500 D12.776.631.650.575.281.381.500 Dabigatran D3.438.103.280 D3.633. ... Enkephalin, Methionine D12.776.641.650.575.281.381 D12.776.631.650.575.281.381 Enkephalins D12.776.641.650.575.281 D12.776. ... D12.776.641.650.575.281.600 D12.776.631.650.575.281.600 Enkephalin, Leucine D12.776.641.650.575.281.231 D12.776.631.650.575.281 ...
... d-Ala(2),N-MePhe(4),Gly-ol(5)]enkephalin binding assay was not significantly changed by a deletion of the dopamine D(3) ... The &mgr;-opioid receptor in the brain determined by the [tylosil-3,5-(3)H(N)]-[ ...
D-Ala, MePhe4, Gly-ol5] (DAGO), low levels of kappa opioid receptor binding using the radioligand [3H]-[ethylketocyclazocine] ( ... Leu-enkephalin, and an absence of delta opioid receptor binding with the radioligand [3H]-[D-A1a2, D-Leu5]-enkephalin (DADLE) ... There was no reresponse to changes in pO2 from more than 500 mm. Hg to 59.6 mm. Hg, but when pO2 was lowered below 50 mm. Hg ... It was found that there was no response to changes in pCO2 from 38.1 mm. Hg to 26.6 mm. Hg. but there was some constriction of ...
... enkephalin) nor the μ-opioid agonist, DAMGO (Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol enkephalin) elevated [Ca2+](i) when applied alone. ... enkephalin) nor the μ-opioid agonist, DAMGO (Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol enkephalin) elevated [Ca2+](i) when applied alone. ... enkephalin) nor the μ-opioid agonist, DAMGO (Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol enkephalin) elevated [Ca2+](i) when applied alone. ... enkephalin) nor the μ-opioid agonist, DAMGO (Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol enkephalin) elevated [Ca2+](i) when applied alone. ...
Analgesics, Opioid; Animals; Calcium; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Male; Pituitary Gland, Posterior; Presynaptic ... N-Me-Phe(4),Gly5-ol]-Enkephalin (DAMGO), a MOR agonist, that is blocked by D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP), a ... 2014 Mar 5;34(10):3733-42. doi: 10.1523/JNEUROSCI.2505-13.2014. Link to article on publishers site ...
Yong Q-C, Cheong JL, Hua F, Deng L-W, Khoo YM, Lee H-S, Perry A, Wood M, Whiteman M, Bian J-S, et al (2011). Regulation of ... N-Me-Phe(4),Gly(5)-ol]-Enkephalin, a selective μ-opioid receptor agonist. Blockade of extracellular-regulated protein kinase 1/ ... Gly(5)-ol]-Enkephalin, a selective μ-opioid receptor agonist. Blockade of extracellular-regulated protein kinase 1/2 (ERK1/2) ... Yong Q-C, Cheong JL, Hua F, Deng L-W, Khoo YM, Lee H-S, Perry A, Wood M, Whiteman M, Bian J-S, et al (2011). Regulation of ...
... d-Ala-Gly-MePhe-Glyol (DAMGO) were generously donated by the National Institute on Drug Abuse (NIDA; Bethesda, MD). Idazoxan ... A, Met-enkephalin (ME, 30 μm, indicated bybar under trace) hyperpolarized the neuron (from −71 mV, −30 pA applied current; ... Andrade et al., 1983; Christie et al., 1987), but a small (0.6 Hz,Kogan et al., 1992) excitation, representing only a fraction ... Andrade et al., 1983; Christie et al., 1987; Wimpey et al., 1989; Kennedy and Henderson, 1991, 1992). For example, although ...
The mu-selective opioid peptide [D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin (DAGO) reversibly depressed… ... Ala(2)-MePhe(4)-Gly(5)-, Animals, Barium/pharmacology, Bicuculline/pharmacology, Dendrites/chemistry, Enkephalin, Enkephalins/ ... Tags: 1991, 2-Amino-5-phosphonovalerate/pharmacology, Action Potentials/drug effects, ...
  • 4. Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats. (nih.gov)
  • 5. Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats. (nih.gov)
  • Importantly, μ-opioid receptor agonist [D-Ala 2 , N -Me-Phe 4 ,Gly 5 ]-ol-enkephalin (DAMGO) significantly elevated the mechanical thresholds of nociceptive Aδ and C fibres. (biomedcentral.com)
  • These effects were blocked by DAMGO washout and pre-treatment with the selective μ-opioid receptor antagonist Cys 2 -Tyr 3 -Orn 5 -Pen 7 -amide. (biomedcentral.com)
  • METHODS: SH-SY5Y cells (passage 70-80) were used to obtain ketamine dose-response curves for inhibition of 0.4 nM [(3)H][D-Ala(2),MePhe(4),Gly(ol)(5)] enkephalin (DAMGO) binding to mu(2) opioid receptors and of forskolin (1 microM)-stimulated cyclic AMP (cAMP) formation. (ketamine.co.uk)
  • Methods Patch-clamp recordings of miniature excitatory postsynaptic currents (mEPSCs) and dorsal root evoked currents (eEPSC) in spinal cord slices superficial dorsal horn neurons were used to evaluate the effect of mu OR agonist [D-Ala(2), N-Me-Phe(4), Gly(5)-ol]-enkephalin (DAMGO), CCL2, TRPV1 antagonist SB366791 and minocycline. (cas.cz)
  • SB-612111 had no intrinsic agonistic activity and did not affect the GIRK current induced by [D-Ala 2 , N-Me-Phe 4 , Gly 5 -ol]-enkephalin, a mu-opioid receptor agonist, when tested at concentrations of up to 1 μM. (sri.com)
  • An enkephalin analog that selectively binds to the MU OPIOID RECEPTOR . (nih.gov)
  • The mouse mu opioid receptor (OPRM1) gene undergoes extensive alternative splicing at both the 3'- and 5'-ends of the gene. (biomedcentral.com)
  • This study was undertaken to examine the receptor selectivity of Met-enkephalin-Arg6-Phe7 (MERF) employing radioreceptor binding assays in human cerebral cortex membranes, and to elucidate the responsible receptors that mediate the regulatory action of MERF on high (20 mM) K+-stimulated release of [3H]norepinephrine ([3H]-NE) in rat cortex slices. (nih.gov)
  • This study quantitatively investigated the effect of (−)- cis -1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1 -yl]methyl]-6,7,8,9-tetrahydro-5 H -benzocyclohepten-5-ol (SB-612111), a novel non-peptide ligand of NOP receptor, on the native NOP receptors in the midbrain ventrolateral periaqueductal gray (vlPAG), a crucial region for pain regulation. (sri.com)
  • The goal of this study was to investigate the crosstalk between the mu OR, transient receptor potential vanilloid 1 (TRPV1) receptor and C-C motif ligand 2 (CCL2) chemokine and the involvement of spinal microglia in the modulation of opioid analgesia. (cas.cz)
  • 2. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. (nih.gov)
  • 18. Effect of MK-801 on the antinociceptive effect of [D-Ala(2),N-MePhe(4), Gly-ol(5)]enkephalin in diabetic mice. (nih.gov)
  • However, because this agent does not produce opioid-like respiratory depression, it might not interact with mu(2) opioid receptors. (ketamine.co.uk)
  • Therefore, we have studied the interaction of ketamine with mu(2) opioid receptors expressed in SH-SY5Y cells. (ketamine.co.uk)
  • CONCLUSION: The present study indicates that a clinically relevant concentration of ketamine interacts with mu(2) opioid receptors. (ketamine.co.uk)
  • In both mice and humans 5' splicing generates a number of exon 11-containing variants. (biomedcentral.com)
  • [ 5 , 6 ] These guidelines recommend against using opioid analgesics for CNCP as a first-line medication because the harms frequently outweigh the benefits. (medscape.com)
  • Two countries at the epicenter of the opioid crisis, Canada and the United States, [ 1-4 ] recently released clinical practice guidelines for opioid prescribing for chronic noncancer pain (CNCP). (medscape.com)
  • 8. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord. (nih.gov)
  • Thus, we investigated opioid effects on intracellular Ca 2+ in cultured rat hippocampal neurons by using fura-2-based microscopic Ca 2+ imaging. (jneurosci.org)